Editorial Standards & Medical Review Board
How our editorial board fact-checks, audits, and ensures clinical transparency across every piece of scientific content on this reference platform.
Dr. Marcus Vance, PharmD
Dr. Marcus Vance holds a Doctor of Pharmacy (PharmD) with advanced residency specialization in metabolic pharmacotherapy and botanical pharmacokinetics. With over 14 years of clinical experience auditing dietary supplement formulations, Dr. Vance oversees the technical accuracy of our Supplement Facts transcriptions, pharmacokinetic mechanism models, drug interaction contraindications, and laboratory Certificate of Analysis (CoA) verifications.
Our 4-Step Clinical Fact-Checking Protocol
- Primary Sourcing from PubMed & ClinicalTrials.gov: We reject secondary marketing claims. Every botanical statement is validated against published peer-reviewed human clinical trials or systematic Cochrane reviews.
- Dose vs. Research Dose Honesty: If an active herb in our proprietary blend is dosed below clinical trial thresholds (such as 200 mg total blend vs. 500 mg standalone study doses), our editorial policy mandates that we explicitly disclose this discrepancy to readers.
- Explicit Medication Contraindications: Because adaptogenic herbs (Gymnema, Licorice, Panax Ginseng) and Chromium can potentiate hypoglycemic medications or alter blood pressure therapies, our reviewers enforce bold warning disclosures on every product page.
- No Promotional Medical Claims: In accordance with FTC and FDA statutory guidelines, we strictly prohibit framing Olivaro as a replacement for prescription GLP-1 agonists, insulin therapies, metformin, or other standard-of-care medical treatments.
Conflict of Interest & Independence Statement
The editorial review board operates under strict editorial autonomy. Content reviews are conducted exclusively to evaluate botanical science, label accuracy, and user safety. Authors and medical reviewers receive fixed professional compensation that is completely independent of sales volume, affiliate conversion metrics, or product refund frequencies.
